Description

SMS Pharmaceuticals Ltd (Scrip Code 532815) lists 50 lakh equity shares issued to promoters on preferential basis pursuant to warrant conversion, with lock-in until October 2027.

Summary

BSE has listed 50,00,000 new equity shares of SMS Pharmaceuticals Ltd (Scrip Code 532815) issued to promoters on a preferential basis pursuant to warrant conversion. The shares are listed and permitted to trade from November 7, 2025, with a lock-in period until October 30, 2027.

Key Points

  • 50,00,000 equity shares of Re. 1/- each issued at premium of Rs. 126/-
  • Issued to promoters on preferential basis through warrant conversion
  • Issue price: Rs. 127/- per share
  • Total fundraising: Rs. 63.5 crore (50 lakh shares × Rs. 127)
  • Shares rank pari-passu with existing equity shares
  • ISIN: INE812G01025
  • Distinctive numbers: 88652031 to 93652030

Regulatory Changes

No regulatory changes introduced by this circular.

Compliance Requirements

  • Trading members are informed of the new securities listing
  • All 50 lakh shares are subject to mandatory lock-in requirements
  • Shares cannot be transferred or sold until the lock-in period expires

Important Dates

  • Date of Allotment: September 10, 2025
  • Trading Commencement: November 7, 2025 (Friday)
  • Lock-in Expiry: October 30, 2027
  • Lock-in Duration: Approximately 2 years from allotment

Impact Assessment

Market Impact: Minimal immediate impact as all shares are locked-in until October 2027. The preferential allotment to promoters strengthens their stake and indicates confidence in the company.

Dilution: Existing public shareholders will experience dilution, though the exact percentage depends on the pre-issue share capital.

Liquidity: No impact on tradable float as shares are locked-in for 2 years.

Capital Raising: The company has raised Rs. 63.5 crore through this preferential issue, which may be used for business expansion, debt reduction, or working capital requirements.

Impact Justification

Routine listing of preferential shares to promoters with standard lock-in; limited impact on public shareholders as shares are locked for 2 years